Lyons Gary A's Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed Oct 4, 2024
- Accession no.
- 0001415889-24-024795
- Filed
- Oct 4, 2024
- Trade date
- Oct 4, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $589.1K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lyons Gary ACIK 0001123343 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2024 | Common Stock | MOption exerciseAcquired | +40,000 | $10.48 | +$419,200 | 91,000 | Direct | |
| Oct 4, 2024 | Common Stock | SSaleDisposed | −21,179 | $14.35 | −$303,918.65 | 69,821 | Direct | |
| Oct 4, 2024 | Common Stock | SSaleDisposed | −18,821 | $15.15 | −$285,138.15 | 51,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2024 | Common Stock | MOption exerciseAcquired | +40,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.